ICD-10 Diagnosis Code Q82.1

Xeroderma pigmentosum

Diagnosis Code Q82.1

ICD-10: Q82.1
Short Description: Xeroderma pigmentosum
Long Description: Xeroderma pigmentosum
This is the 2017 version of the ICD-10-CM diagnosis code Q82.1

Code Classification
  • Congenital malformations, deformations and chromosomal abnormalities
    • Other congenital malformations (Q80-Q89)
      • Other congenital malformations of skin (Q82)

Information for Medical Professionals

Diagnostic Related Groups
The diagnosis code Q82.1 is grouped in the following Diagnostic Related Group(s) (MS-DRG v33.0)


Convert to ICD-9 Additional informationCallout TooltipGeneral Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

Present on Admission (POA) Additional informationCallout TooltipPresent on Admission
The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.

The code Q82.1 is exempt from POA reporting.

  • Congenital hypoplasia of gonad
  • Congenital pigmentary skin anomalies
  • Mental retardation, dwarfism, and gonadal hypoplasia due to xeroderma pigmentosa
  • Neurologic xeroderma pigmentosum
  • Non-neurologic xeroderma pigmentosum
  • Pigmented xerodermoid
  • Reproductive system hereditary disorder
  • Xeroderma pigmentosum
  • Xeroderma pigmentosum, group A
  • Xeroderma pigmentosum, group B
  • Xeroderma pigmentosum, group C
  • Xeroderma pigmentosum, group D
  • Xeroderma pigmentosum, group E
  • Xeroderma pigmentosum, group F
  • Xeroderma pigmentosum, group G
  • Xeroderma pigmentosum, variant form

Information for Patients

Skin Conditions

Also called: Cutaneous disorders, Dermatologic disorders

Your skin is your body's largest organ. It covers and protects your body. Your skin

  • Holds body fluids in, preventing dehydration
  • Keeps harmful microbes out, preventing infections
  • Helps you feel things like heat, cold, and pain
  • Keeps your body temperature even
  • Makes vitamin D when the sun shines on it

Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

  • Acrodermatitis
  • Cradle cap
  • Cryotherapy
  • Cutaneous skin tags
  • Dry skin -- self-care
  • Erythema multiforme
  • Granuloma annulare
  • Keratosis pilaris
  • Lichen planus
  • Milia
  • Sebaceous cyst
  • Seborrheic dermatitis
  • Seborrheic keratosis
  • Skin lesion removal
  • Skin lesion removal-aftercare
  • Stasis dermatitis and ulcers

[Read More]

Xeroderma pigmentosum Xeroderma pigmentosum, which is commonly known as XP, is an inherited condition characterized by an extreme sensitivity to ultraviolet (UV) rays from sunlight. This condition mostly affects the eyes and areas of skin exposed to the sun. Some affected individuals also have problems involving the nervous system.The signs of xeroderma pigmentosum usually appear in infancy or early childhood. Many affected children develop a severe sunburn after spending just a few minutes in the sun. The sunburn causes redness and blistering that can last for weeks. Other affected children do not get sunburned with minimal sun exposure, but instead tan normally. By age 2, almost all children with xeroderma pigmentosum develop freckling of the skin in sun-exposed areas (such as the face, arms, and lips); this type of freckling rarely occurs in young children without the disorder. In affected individuals, exposure to sunlight often causes dry skin (xeroderma) and changes in skin coloring (pigmentation). This combination of features gives the condition its name, xeroderma pigmentosum.People with xeroderma pigmentosum have a greatly increased risk of developing skin cancer. Without sun protection, about half of children with this condition develop their first skin cancer by age 10. Most people with xeroderma pigmentosum develop multiple skin cancers during their lifetime. These cancers occur most often on the face, lips, and eyelids. Cancer can also develop on the scalp, in the eyes, and on the tip of the tongue. Studies suggest that people with xeroderma pigmentosum may also have an increased risk of other types of cancer, including brain tumors. Additionally, affected individuals who smoke cigarettes have a significantly increased risk of lung cancer.The eyes of people with xeroderma pigmentosum may be painfully sensitive to UV rays from the sun. If the eyes are not protected from the sun, they may become bloodshot and irritated, and the clear front covering of the eyes (the cornea) may become cloudy. In some people, the eyelashes fall out and the eyelids may be thin and turn abnormally inward or outward. In addition to an increased risk of eye cancer, xeroderma pigmentosum is associated with noncancerous growths on the eye. Many of these eye abnormalities can impair vision.About 30 percent of people with xeroderma pigmentosum develop progressive neurological abnormalities in addition to problems involving the skin and eyes. These abnormalities can include hearing loss, poor coordination, difficulty walking, movement problems, loss of intellectual function, difficulty swallowing and talking, and seizures. When these neurological problems occur, they tend to worsen with time.Researchers have identified at least eight inherited forms of xeroderma pigmentosum: complementation group A (XP-A) through complementation group G (XP-G) plus a variant type (XP-V). The types are distinguished by their genetic cause. All of the types increase skin cancer risk, although some are more likely than others to be associated with neurological abnormalities.
[Read More]
Previous Code
Previous Code Q82.0
Next Code
Q82.2 Next Code